Document Report Card
Basic Information
ID: ALA5244252
Journal: Eur J Med Chem
Title: PROTAC: A promising technology for cancer treatment.
Authors: Zhou X, Dong R, Zhang JY, Zheng X, Sun LP.
Abstract: Proteolysis-targeting chimeric molecules (PROTACs), which attract much more attention today, may be a potential way to treat cancer. PROTACs are made up of ligands of target proteins, E3 ligase recruiting elements and linkers. PROTACs can hijack the intracellular inherent ubiquitin proteasome system in cells to degrade different target proteins. PROTACs targeting different cancer-related proteins have been successfully developed and outperform small inhibitors, the traditional way of treating cancer. In this review, we focus on PROTACs targeting cancer-related proteins and their superiority over inhibitors.
CiteXplore: 32698111